S100A8 and S100A9 in inflammation and cancer

被引:615
作者
Gebhardt, Christoffer [1 ]
Nemeth, Julia [1 ]
Angel, Peter [1 ]
Hess, Jochen [1 ]
机构
[1] German Canc Res Ctr, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany
关键词
S100; RAGE; AP-1; NF-kappa B; inflammation; carcinogenesis; CALCIUM-BINDING PROTEINS; NF-KAPPA-B; SQUAMOUS-CELL CARCINOMA; TUMOR-NECROSIS-FACTOR; COMPARATIVE GENOMIC HYBRIDIZATION; ADVANCED GLYCATION ENDPRODUCTS; MALIGNANCY-ASSOCIATED REGIONS; GENE-EXPRESSION; TRANSENDOTHELIAL MIGRATION; END-PRODUCTS;
D O I
10.1016/j.bcp.2006.05.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Calprotectin (S100A8/A9), a heterodimer of the two calcium-binding proteins S100A8 and S100A9, was originally discovered as immunogenic protein expressed and secreted by neutrophils. Subsequently, it has emerged as important pro-inflammatory mediator in acute and chronic inflammation. More recently, increased S100A8 and S100A9 levels were also detected in various human cancers, presenting abundant expression in neoplastic tumor cells as well as infiltrating immune cells. Although, many possible functions have been proposed for S100A8/A9, its biological role still remains to be defined. Altogether, its expression and potential cytokine-like function in inflammation and in cancer suggests that S100A8/A9 may play a key role in inflammation-associated cancer. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1622 / 1631
页数:10
相关论文
共 143 条
  • [1] ALOWAMI S, 2003, BMC DERMATOL, V3
  • [2] Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma
    Arai, K
    Yamada, T
    Nozawa, R
    [J]. MEDICAL ONCOLOGY, 2000, 17 (03) : 183 - 188
  • [3] S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation
    Arai, K
    Teratani, T
    Kuruto-Niwa, R
    Yamada, T
    Nozawa, R
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (08) : 1179 - 1187
  • [4] Arai K, 2001, ONCOL REP, V8, P591
  • [5] S100P promotes pancreatic cancer growth, survival, and invasion
    Arumugam, T
    Simeone, DM
    Van Golen, K
    Logsdon, CD
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5356 - 5364
  • [6] The role of the complement system in ischemia-reperfusion injury
    Arumugam, TV
    Shiels, IA
    Woodruff, TM
    Granger, DN
    Taylor, SM
    [J]. SHOCK, 2004, 21 (05): : 401 - 409
  • [7] Tumor necrosis factor or tumor promoting factor?
    Balkwill, F
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 135 - 141
  • [8] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [9] Pathway-specific profiling identifies the NF-κB-dependent tumor necrosis factor α-regulated genes in epidermal keratinocytes
    Banno, T
    Gazel, A
    Blumenberg, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) : 18973 - 18980
  • [10] BELMAN S, 1972, CANCER RES, V32, P450